According to findings from China Antihypertensive Trial in Acute Ischemic Stroke (CATIS) published in the Journal of the American Medical Association, use of antihypertensive drugs to lower systolic blood pressure by close to 13% as part of acute treatment of ischemic stroke did not reduce early mortality or disability compared with patients who did not receive antihypertensive therapy. At 14 days after randomization, there were 683 events among patients who received early aggressive antihypertensive therapy versus 681 events in the control group and at 3 months, there were 500 additional events in the treatment arm versus 502 among controls, said Jiang He, MD, PhD, of Tulane University School of Public Health in New Orleans. (MedPage)

Blogger PostEmailFacebookGoogle GmailShare